Transcatheter arterial chemoembolisation for hepatocellular carcinoma in cirrhosis: feasibility of hepatic resection

Date 29 June 2016
Event ESMO World Congress on Gastrointestinal Cancer 2016
Session ESMO World Congress on Gastrointestinal Cancer 2016 - Abstracts book
Presenter K. Kadirov
Citation Annals of Oncology (2016) 27 (2): 86-101. 10.1093/annonc/mdw201
Authors K. Kadirov1, O. Nematov2, M. Djuraev1, D. Egamberdiev1
  • 1National Research Center of Oncology, Tashkent, Uzbekistan, /
  • 2National Cancer Research Center, Tashkent, Uzbekistan, /

Abstract

Hepatocellular carcinoma (HCC) is the fifth most common cancer in the world. It mostly occurs in patients with cirrhosis. The aim of investigation is to evaluate the efficiency of transcatheter arterial chemoembolization (TACE) for unresectable HCC in cirrhosis and use of it in preoperative stage.